Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Latent TGF-beta1 activation by platelets.

Robert Blakytny1, Anna Ludlow, Gail E M Martin

  • 1Department of Cancer Research, Fachklinik Hornheide, University of Münster, Münster, Germany.

Journal of Cellular Physiology
|February 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-border investigation of a tuberculosis outbreak in Vienna linked to a multi-country cluster among foreign-born individuals, Europe, 2021 to 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

The Peripheral Lymphatic System Is Impaired by the Loss of Neuronal Control Associated with Chronic Spinal Cord Injury.

The American journal of pathology·2022
Same author

Cellular and molecular changes that predispose skin in chronic spinal cord injury to pressure ulcer formation.

International wound journal·2021
Same author

Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes.

Experimental dermatology·2019
Same author

A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging.

JNCI cancer spectrum·2019
Same author

Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants.

BMJ evidence-based medicine·2019

Platelets activate latent transforming growth factor-beta1 (TGF-beta1) through a novel furin-like enzyme mechanism. This finding reveals a new pathway for TGF-beta1 regulation and potential therapeutic targets.

Area of Science:

  • Hematology
  • Molecular Biology
  • Biochemistry

Background:

  • Platelets are a primary source of circulating transforming growth factor-beta1 (TGF-beta1).
  • Platelet activation releases latent TGF-beta1, but the activation mechanism is not fully understood.

Purpose of the Study:

  • To investigate the mechanism by which human platelets activate latent TGF-beta1 upon stimulation.
  • To identify the specific enzymes involved in this activation process.

Main Methods:

  • Human platelets were stimulated with thrombin.
  • Latent TGF-beta1 activation was assessed in platelet releasates.
  • The effect of known TGF-beta activators and furin inhibitors was evaluated.

Main Results:

Related Experiment Videos

  • Platelet activation led to significant latent TGF-beta1 activation.
  • This activation was independent of classical pathways involving TSP-1, M6P/IGF-IIR, or plasmin.
  • Furin inhibitors significantly blocked latent TGF-beta1 activation, indicating a role for a furin-like enzyme.

Conclusions:

  • Human platelets activate latent TGF-beta1 via a novel mechanism involving the release and activity of a furin-like proprotein convertase.
  • This platelet-derived furin-like activity represents a new pathway for TGF-beta1 regulation.
  • This mechanism could be a therapeutic target for conditions involving TGF-beta1, such as fibrosis and arteriosclerosis.